Alphabet reported second-quarter revenue that surpassed Wall Street expectations, driven by an 82% year-over-year increase in its cloud computing division as enterprise AI demand accelerates.
A federal judge has cast significant doubt on the scientific evidence in thousands of lawsuits alleging Johnson & Johnson's talc products caused ovarian cancer, ordering plaintiffs to provide more specific proof. This development could lead to the dismissal of approximately 69,000 cases consolidated in a New Jersey court.
The enterprise software company surpassed Wall Street estimates for its second quarter and raised its full-year subscription revenue forecast, citing accelerating enterprise demand for its AI platform.
Citi analysts anticipate a positive second-quarter earnings season for paper and packaging companies, citing stable demand and price hikes. The firm identified Sonoco Products and Crown Holdings among its top picks ahead of the reports.
Wolfe Research has identified six engineering and construction stocks, led by top pick MasTec, as prime beneficiaries of surging investment in power infrastructure, renewable energy, and data centers.
Deutsche Bank has lowered its price targets across the IT Services sector, citing a deteriorating demand environment driven by geopolitical uncertainty, rising interest rates, and emerging AI threats ahead of earnings season.
The derivatives exchange operator exceeded Wall Street's second-quarter earnings expectations, driven by strong hedging activity. CEO Terry Duffy addressed investor concerns over perpetual futures, stating the new products are not in demand from the company's core clients.
The U.S. Food and Drug Administration has launched an investigation into a new cyclospora outbreak involving 72 cases, sparking investor concern and sending shares of major restaurant chains lower.
Shares of several fast-casual restaurant chains, including Sweetgreen and Chipotle, declined on Wednesday after the U.S. Food and Drug Administration announced a new cyclospora outbreak.
